<?xml version="1.0" encoding="UTF-8"?>
<ref id="B73-pharmaceuticals-14-00381">
 <label>73.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Nguyen</surname>
    <given-names>N.M.</given-names>
   </name>
   <name>
    <surname>Tran</surname>
    <given-names>C.N.B.</given-names>
   </name>
   <name>
    <surname>Phung</surname>
    <given-names>L.K.</given-names>
   </name>
   <name>
    <surname>Duong</surname>
    <given-names>K.T.H.</given-names>
   </name>
   <name>
    <surname>Huynh</surname>
    <given-names>H.L.A.</given-names>
   </name>
   <name>
    <surname>Farrar</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Nguyen</surname>
    <given-names>Q.T.H.</given-names>
   </name>
   <name>
    <surname>Tran</surname>
    <given-names>H.T.</given-names>
   </name>
   <name>
    <surname>Nguyen</surname>
    <given-names>C.V.V.</given-names>
   </name>
   <name>
    <surname>Merson</surname>
    <given-names>L.</given-names>
   </name>
  </person-group>
  <article-title>A randomized, double-blind placebo controlled trial of balapiravir, a polymerase inhibitor, in adult dengue patients</article-title>
  <source>J. Infect. Dis.</source>
  <year>2013</year>
  <volume>207</volume>
  <fpage>1442</fpage>
  <lpage>1450</lpage>
  <pub-id pub-id-type="doi">10.1093/infdis/jis470</pub-id>
  <pub-id pub-id-type="pmid">22807519</pub-id>
 </element-citation>
</ref>
